Daré Bioscience, Inc.
DARE
$1.92
$0.073.78%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.16M | 1.03M | -57.10K | -17.70K | 25.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.16M | 1.03M | -57.10K | -17.70K | 25.90K |
| Cost of Revenue | -2.53M | -1.13M | -7.50M | -6.00M | -6.00M |
| Gross Profit | 3.68M | 2.16M | 7.45M | 5.98M | 6.02M |
| SG&A Expenses | 8.70M | 8.76M | 9.18M | 8.72M | 8.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.13M | 14.58M | 17.41M | 18.46M | 22.04M |
| Operating Income | -11.97M | -13.55M | -17.47M | -18.48M | -22.01M |
| Income Before Tax | -12.02M | -13.40M | -17.46M | -18.60M | -1.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.02 | -13.40 | -17.46 | -18.60 | -1.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.02M | -13.40M | -17.46M | -18.60M | -1.68M |
| EBIT | -11.97M | -13.55M | -17.47M | -18.48M | -22.01M |
| EBITDA | -9.94M | -11.90M | -16.35M | -17.83M | -21.80M |
| EPS Basic | -1.04 | -1.33 | -1.92 | -2.19 | -0.20 |
| Normalized Basic EPS | -0.65 | -0.83 | -1.20 | -1.37 | -0.13 |
| EPS Diluted | -1.14 | -1.43 | -1.92 | -2.19 | -0.22 |
| Normalized Diluted EPS | -0.65 | -0.83 | -1.20 | -1.37 | -0.13 |
| Average Basic Shares Outstanding | 50.43M | 44.67M | 38.40M | 34.18M | 33.72M |
| Average Diluted Shares Outstanding | 50.43M | 44.67M | 38.40M | 34.18M | 33.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |